Alle Arbeitgeber
HMNC Holding GmbH
Details
-
Unternehmenstyp
GmbH
About HMNC Holding GmbH
HMNC Holding GmbH is a precision psychiatry biopharmaceutical company focused on developing personalized treatments for depression through predictive genetic selection tools. The company's pipeline includes innovative programs targeting Major Depressive Disorder (MDD), such as Nelivabon, Cortibon, and KET01, which utilize proprietary genetic selection methods to enhance treatment efficacy.
Career Opportunities
HMNC Holding GmbH offers a dynamic working environment that fosters professional growth and collaboration across various disciplines. Employees are encouraged to engage in cross-functional projects, contributing to the development of groundbreaking therapies in mental health.
- Collaborative work culture
- Opportunities for professional development
- Engagement in cutting-edge research
